Live feed16:45:07·181dINSIDERFilingvia QuantisnowPresident and Head of R&D Nagendran Sukumar sold $942,000 worth of shares (200,000 units at $4.71), was granted 427,000 shares and exercised 200,000 shares at a strike of $1.15, increasing direct ownership by 42% to 1,433,439 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TSHA· Taysha Gene Therapies Inc.Health CareOriginal source
